Search research articles
Contact Us
Filters
Showing results (311-320 of 360) with videos related to
Page
of 36
Sort By:
Open Forum Infectious Diseases
|
June 10, 2026
Clinical Impact of Linezolid Therapeutic Drug Monitoring on the Tolerability of Prolonged Courses in the Outpatient Setting
Jeffrey M Harrington, Jerod L Nagel, Samantha Sallerson, et al.
British Journal of Clinical Pharmacology
|
January 27, 2022
Muscle mass affects paclitaxel systemic exposure and may inform personalized paclitaxel dosing
Daniel L Hertz, Li Chen, N Lynn Henry, et al.
Chest
|
July 22, 2021
COVID-19 and Risk of VTE in Ethnically Diverse Populations
Alan S Go, Kristi Reynolds, Grace H Tabada, et al.
Scientific Reports
|
February 21, 2020
Small molecule activation of metabolic enzyme pyruvate kinase muscle isozyme 2, PKM2, circumvents photoreceptor apoptosis
Thomas J Wubben, Mercy Pawar, Eric Weh, et al.
The Journal of Trauma and Acute Care Surgery
|
October 25, 2021
A single dose of valproic acid improves neurologic recovery and decreases brain lesion size in swine subjected to an isolated traumatic brain injury
Glenn K Wakam, Ben E Biesterveld, Manjunath P Pai, et al.
The Review of Scientific Instruments
|
August 15, 2024
Feedback based gas sensing setup for ppb to ppm level sensing
Abin Tom, Dharmendra Kumar Singh, Vishal Krishna Shaw, et al.
Plos One
|
June 8, 2018
Characterization of genetic changes associated with daptomycin nonsusceptibility in Staphylococcus aureus
Zhuo Ma, Erica Lasek-Nesselquist, Jackson Lu, et al.
The Journal of Trauma and Acute Care Surgery
|
July 12, 2017
Valproic acid decreases brain lesion size and improves neurologic recovery in swine subjected to traumatic brain injury, hemorrhagic shock, and polytrauma
Vahagn C Nikolian, Patrick E Georgoff, Manjunath P Pai, et al.
Clinical Pharmacokinetics
|
May 13, 2017
Safety and Tolerability of Intravenous Valproic Acid in Healthy Subjects: A Phase I Dose-Escalation Trial
Patrick E Georgoff, Vahagn C Nikolian, Tess Bonham, et al.
JAMA Network Open
|
March 13, 2023
Assessment of the Risk of Venous Thromboembolism in Nonhospitalized Patients With COVID-19
Margaret C Fang, Kristi Reynolds, Grace H Tabada, et al.
Page
of 36
Search research articles
Search
Showing results (311-320 of 360) with videos related to
Sort By:
Page
of 36
Open Forum Infectious Diseases
|
June 10, 2026
Clinical Impact of Linezolid Therapeutic Drug Monitoring on the Tolerability of Prolonged Courses in the Outpatient Setting
Jeffrey M Harrington, Jerod L Nagel, Samantha Sallerson, et al.
British Journal of Clinical Pharmacology
|
January 27, 2022
Muscle mass affects paclitaxel systemic exposure and may inform personalized paclitaxel dosing
Daniel L Hertz, Li Chen, N Lynn Henry, et al.
Chest
|
July 22, 2021
COVID-19 and Risk of VTE in Ethnically Diverse Populations
Alan S Go, Kristi Reynolds, Grace H Tabada, et al.
Scientific Reports
|
February 21, 2020
Small molecule activation of metabolic enzyme pyruvate kinase muscle isozyme 2, PKM2, circumvents photoreceptor apoptosis
Thomas J Wubben, Mercy Pawar, Eric Weh, et al.
The Journal of Trauma and Acute Care Surgery
|
October 25, 2021
A single dose of valproic acid improves neurologic recovery and decreases brain lesion size in swine subjected to an isolated traumatic brain injury
Glenn K Wakam, Ben E Biesterveld, Manjunath P Pai, et al.
The Review of Scientific Instruments
|
August 15, 2024
Feedback based gas sensing setup for ppb to ppm level sensing
Abin Tom, Dharmendra Kumar Singh, Vishal Krishna Shaw, et al.
Plos One
|
June 8, 2018
Characterization of genetic changes associated with daptomycin nonsusceptibility in Staphylococcus aureus
Zhuo Ma, Erica Lasek-Nesselquist, Jackson Lu, et al.
The Journal of Trauma and Acute Care Surgery
|
July 12, 2017
Valproic acid decreases brain lesion size and improves neurologic recovery in swine subjected to traumatic brain injury, hemorrhagic shock, and polytrauma
Vahagn C Nikolian, Patrick E Georgoff, Manjunath P Pai, et al.
Clinical Pharmacokinetics
|
May 13, 2017
Safety and Tolerability of Intravenous Valproic Acid in Healthy Subjects: A Phase I Dose-Escalation Trial
Patrick E Georgoff, Vahagn C Nikolian, Tess Bonham, et al.
JAMA Network Open
|
March 13, 2023
Assessment of the Risk of Venous Thromboembolism in Nonhospitalized Patients With COVID-19
Margaret C Fang, Kristi Reynolds, Grace H Tabada, et al.
Page
of 36